This registration enables companies to register the products (Orodispersible films and Transdermal systems) in UAE for commercialization
These melas serve as platforms to attract thousands of people to avail quality healthcare services along with essential medicines and diagnostic services
GAAP net loss of $1.2 billion and GAAP diluted EPS of $(3.07)
Sun Pharma's Dadra facility receives OAI status from US FDA
First and only AKT inhibitor approved in Japan for breast cancer patients with specific biomarker alterations
From only 80 Jan Aushadhi Kendras in 2014, there are around 11,000 units operating across the country today
Sadhana Nitro Chem's plant is the second plant in the world to manufacture pAP from Nitrobenzene
Collaborative Research in AYUSH is extremely important as it bridges the gap between traditional knowledge and modern scientific research
Launch of Indian public health standards for Ayush healthcare facilities
ICMR’s budgetary allowance has increased by 4-fold in the past 10 years, showcasing our commitment towards Health Research
Subscribe To Our Newsletter & Stay Updated
_256_275.jpg)